SERA
Sera Prognostics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.02
+2.02%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 88.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.34x
- Price / sales
- 1138.40x
- Price / cash flow
- -2.88x
Enterprise value
- Enterprise value
- $36.2M
- EV / sales
- 517.77x
- EV / EBITDA
- -1.12x
- EV / EBIT
- -0.97x
- Market cap
- $79.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026